德源药业：关于别嘌醇片获国家药监局签发药品注册证书的公告

Core Viewpoint - Deyuan Pharmaceutical has received approval from the National Medical Products Administration (NMPA) for its Allopurinol tablets, which are classified as Category 3 chemical drugs, and this approval is considered equivalent to passing the consistency evaluation [2] Company Summary - On December 9, 2025, Deyuan Pharmaceutical Co., Ltd. was granted a drug registration certificate for Allopurinol tablets by NMPA [2]